Randomized Control Trial (RCT) of Early Palliative Care for HCC
Status unconfirmed · Not applicable
Conditions studied: Carcinoma, Hepatocellular
In brief
The purpose of this research study is to evaluate the effect of early palliative care consultation on quality of life, use of hospital resources, end-of-life care and survival among Hepatocellular Carcinoma (HCC) patients with advanced End Stage Live Disease not eligible for potentially curative or local area therapy. Half of patients will receive early palliative care at diagnosis of HCC and other half will receive palliative care when all standard therapy treatments have been exhausted.
Key facts
- Study ID
- NCT02556619
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 72
- Starts
- 2019-04-02
- Expected to finish
- 2021-09-01
- Last updated by the study team
- 2021-04-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed HCC by biopsy or liver protocol CT scan or MRI characteristics
- Permanent street address with Harris County, Texas and consent to study participation
- English or Spanish speaking with ability to respond to the QoL questionnaires
- Child-Pugh C, not eligible for liver transplantation (TXP), surgical resection, ablation, locoregional or systemic therapy
- Child-Pugh C, eligible for systemic chemotherapy (Sorafenib), not eligible for TXP, surgical resection, ablation or locoregional therapy
- Child-Pugh A or B, not eligible for surgical resection or ablation (>3 lesions or 2 lesions with one being >5cm)
- Child-Pugh A, not eligible for TXP, surgical resection, ablation or locoregional therapy
You may not qualify if…
- Primary modality of treatment is potentially curative TXP, surgical resection or ablation as deemed by GI MDC
- Child-Pugh A or B (up to 2 lesions < 5cm in size)
- Medical (e.g. severe encephalopathy), psychological or social conditions that may interfere with the patient's participation in the study or evaluation of the study results
- Any medical condition (acute myocardial infarction or stroke) that could jeopardize the safety of the patient and his/her compliance in the study
- Vulnerable population (inmates in jail or prison)
- Non-English or Non-Spanish Speaking patients.
Where it is running
- Lyndon Baines Johnson (LBJ) General Hospital — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.